568.37
0.07%
+0.41
Handel nachbörslich:
568.37
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Chemed Corp. Aktie (CHE) Neueste Nachrichten
Should iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV) Be on Your Investing Radar?
Zacks Investment Research
Jump Financial LLC Makes New Investment in Chemed Co. (NYSE:CHE) - MarketBeat
MarketBeat
Death Care Merchandise and Services Market 2031 Business Insights with Key Trend Analysis | Leading Companies ... - Amoré
Amoré
Swiss National Bank Decreases Stock Holdings in Chemed Co. (NYSE:CHE) - Defense World
Defense World
New York Life Investment Management LLC Takes $973000 Position in Chemed Co. (NYSE:CHE) - Defense World
Defense World
Chemed Co. (NYSE:CHE) Shares Bought by Van ECK Associates Corp - Defense World
Defense World
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024 - Yahoo Canada Finance
Yahoo Canada Finance
Chemed Co. (NYSE:CHE) Shares Bought by First Trust Direct Indexing L.P. - Defense World
Defense World
International Assets Investment Management LLC Purchases New Position in Chemed Co. (NYSE:CHE) - Defense World
Defense World
EHC or CHE: Which Is the Better Value Stock Right Now?
Zacks Investment Research
Chemed Corporation (NYSE:CHE) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View
Zacks Investment Research
Chemed Corp is Now Oversold (CHE) - Nasdaq
Nasdaq
Chemed (CHE) Q1 Earnings Miss Estimates
Zacks Investment Research
Here's Why You Should Retain Chemed (CHE) Stock for Now
Zacks Investment Research
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Zacks Investment Research
Chemed Corp Executive Vice President Spencer Lee Sells Company Shares Chemed Corp Executive Vice President ... - Yahoo Finance
Yahoo Finance
Chemed (CHE) Up 2.5% Since Last Earnings Report: Can It Continue?
Zacks Investment Research
Chemed (CHE) Reaches a New 52-Week High: What's Driving It?
Zacks Investment Research
VITAS CEO Westfall: Market Conditions More Favorable for Hospice Acquisitions - Hospice News
Hospice News
Chemed's (CHE) VITAS Segment Inks New Deal With Covenant Care
Zacks Investment Research
Centene (CNC), Pearl Health Unite to Enhance Value-Based Care
Zacks Investment Research
[UPDATED] VITAS to Acquire Covenant Health and Community Services' Hospice Business for $85M - Hospice News
Hospice News
Here's Why You Should Add Cigna (CI) Stock to Your Portfolio
Zacks Investment Research
Teladoc Health (TDOC) Unveils Solution to Ease Weight Loss
Zacks Investment Research
Should iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV) Be on Your Investing Radar?
Zacks Investment Research
Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference - Yahoo Finance
Yahoo Finance
Is Chemed (CHE) a Solid Growth Stock? 3 Reasons to Think "Yes"
Zacks Investment Research
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Zacks Investment Research
ADUS vs. CHE: Which Stock Is the Better Value Option?
Zacks Investment Research
Chemed (CHE) Q4 Earnings Surpass Estimates, Margins Expand
Zacks Investment Research
Staffing, Capacity Gains 'Catapult' Growth at VITAS - Hospice News
Hospice News
Chemed (CHE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research
Chemed (CHE) Tops Q4 Earnings Estimates
Zacks Investment Research
Chemed Reports Fourth-Quarter 2023 Results - Business Wire
Business Wire
Amedisys (AMED) Q4 Earnings Lag Estimates
Zacks Investment Research
Chemed Corporation Declares Quarterly Dividend of 40 Cents - Yahoo Finance
Yahoo Finance
Here's Why You Should Retain Chemed (CHE) Stock for Now
Zacks Investment Research
Chemed (CHE) Roto-Rooter Growth Continues, Macro Issues Hurt
Zacks Investment Research
The Pennant Group, Inc. (PNTG) Surges 8.4%: Is This an Indication of Further Gains?
Zacks Investment Research
Chemed Corporation to Present at the 42nd Annual JPMorgan Healthcare Conference - Yahoo Finance
Yahoo Finance
DVA vs. CHE: Which Stock Is the Better Value Option?
Zacks Investment Research
Roto-Rooter, Vitas Healthcare parent, Chemed, names new CFO - The Business Journals
The Business Journals
Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO - Business Wire
Business Wire
DVA or CHE: Which Is the Better Value Stock Right Now?
Zacks Investment Research
VITAS Expects a Steady 2024 for Revenue, Growth - Hospice News
Hospice News
Dividend Champion, Contender, And Challenger Highlights: Week Of November 26
Seeking Alpha
Chemed (CHE) Up 4.8% Since Last Earnings Report: Can It Continue?
Zacks Investment Research
DVA vs. CHE: Which Stock Is the Better Value Option?
Zacks Investment Research
Chemed (CHE) Now Trades Above Golden Cross: Time to Buy?
Zacks Investment Research
Kapitalisierung:
|
Volumen (24h):